COMMUNIQUÉ DE PRESSE publié le 08/01/2024 à 08:30, il y a 2 années 4 mois Argo Blockchain PLC Announces £7.8 million ($9.9 million) Placing Argo Blockchain plc, a global leader in cryptocurrency mining, has announced a successful raise of gross proceeds of £7.8 million ($9.9 million) through the issue of new ordinary shares. The proceeds will be used for working capital, repayment of indebtedness, and general corporate purposes. The new ordinary shares will be admitted to the Official List and trading on the Main Market of the London Stock Exchange PLC. For more information, visit www.argoblockchain.com. Blockchain Technology London Stock Exchange Argo Blockchain Plc Cryptocurrency Mining Ordinary Shares
COMMUNIQUÉ RÉGLEMENTÉ publié le 08/01/2024 à 08:22, il y a 2 années 4 mois bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance bioMérieux has acquired LUMED, a software company specializing in clinical decision support systems to optimize antimicrobial prescriptions and monitor healthcare-associated infections. This acquisition reinforces bioMérieux's commitment to combat antimicrobial resistance and improve infection prevention and control through advanced software solutions. BioMérieux LUMED Antimicrobial Resistance Clinical Decision Support System Infection Prevention And Control
COMMUNIQUÉ RÉGLEMENTÉ publié le 08/01/2024 à 08:00, il y a 2 années 4 mois AMOEBA CONFIRME SON ÉLIGIBILITÉ AU DISPOSITIF PEA-PME AMOÉBA confirme son éligibilité au dispositif PEA-PME pour l'année 2024, permettant l'intégration de ses actions dans les portefeuilles PEA PME. La biotech se concentre sur le traitement du risque microbiologique dans les secteurs de l'eau, de la protection des plantes et de la santé AMOEBA Biocontrôle Risque Microbiologique Biotech Industrielle Dispositif PEA-PME
COMMUNIQUÉ RÉGLEMENTÉ publié le 08/01/2024 à 08:00, il y a 2 années 4 mois AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 décembre 2023 Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 décembre 2023 pour Amoéba, société cotée sur Euronext Growth. Ambition de devenir un acteur majeur du traitement du risque microbiologique dans les secteurs de l’eau, de la protection des plantes et de la santé. Commercialisation de produits biocontrôle prévue dès 2025 AMOEBA Biocontrôle Risque Microbiologique Euronext Growth Commercialisation
COMMUNIQUÉ RÉGLEMENTÉ publié le 08/01/2024 à 08:00, il y a 2 années 4 mois Le Groupe PLC, soutenu par l'IDI et Stags, élargit son portefeuille de galéniques avec l’acquisition de Creapharm Cosmetics Le Groupe PLC acquiert Creapharm Cosmetics, CDMO spécialiste du façonnage de produits cosmétiques. Creapharm permet à PLC de diversifier son offre et de renforcer sa position sur le marché des CDMO. L'acquisition inclut le réinvestissement de la famille Placet Acquisition Groupe PLC Creapharm Cosmetics CDMO Produits Cosmétiques
COMMUNIQUÉ DE PRESSE publié le 08/01/2024 à 08:00, il y a 2 années 4 mois Argo Blockchain PLC Announces December Update/Management Change/Share Allotment Argo Blockchain plc, a global leader in cryptocurrency mining, has reported a 4% increase in daily Bitcoin production in December 2023, along with a 25% rise in mining revenue compared to the previous month. The company also disclosed changes in management and share allotment, as well as the grant of equity awards. Argo Blockchain plc is a dual-listed blockchain technology company focusing on large-scale cryptocurrency mining and sustainability. For more information, visit www.argoblockchain.com. Sustainability Argo Blockchain Plc Cryptocurrency Mining Bitcoin Production Mining Revenue
COMMUNIQUÉ DE PRESSE publié le 08/01/2024 à 06:00, il y a 2 années 4 mois Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute Bausch Health Companies Inc. and its gastroenterology business Salix Pharmaceuticals presented oral arguments at the U.S. Court of Appeals for the Federal Circuit regarding the matter of Salix Pharmaceuticals, LTD et al v. Norwich Pharmaceuticals, Inc. No ruling was issued following the oral arguments. The company continues to advocate for the safety of patients benefiting from XIFAXAN® (rifaximin) 550 mg tablets, indicated for hepatic encephalopathy recurrence and irritable bowel syndrome with diarrhea. Salix Pharmaceuticals focuses on the prevention and treatment of gastrointestinal diseases for over 30 years and markets its products to U.S. health care providers. On the other hand, Bausch Health Companies Inc. is a global diversified pharmaceutical company with a mission to improve people's lives through various health care products, primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health. The news release contains forward-looking statements about Bausch Health's future performance and the appeal with respect to intellectual property. The actual results are subject to certain risks and uncertainties. For more information, visit www.bauschhealth.com and connect with them on Twitter and LinkedIn. Bausch Health Companies Inc. Salix Pharmaceuticals Gastrointestinal Diseases XIFAXAN Oral Arguments
COMMUNIQUÉ DE PRESSE publié le 05/01/2024 à 23:30, il y a 2 années 4 mois Smart IMS Strengthens Executive Team, Insurtech Leader Anil Chitale Appointed as Managing Director Smart IMS, a leading technology service and solutions provider, has appointed Anil Chitale as the Managing Director. With over 35 years of experience in the U.S. Insurance industry, Anil's addition to the executive team is expected to further strengthen the company's offerings in the Insurance space. The company aims to leverage Anil's expertise to enhance its business growth and provide world-class technology solutions to its clients in the fast-changing technology and regulatory environment. Smart IMS is headquartered in Plainsboro, New Jersey and offers a wide range of global technology solutions including Application & Infrastructure Management services, Unified Communications, and Life Sciences and Insurance services. Smart IMS Technology Solutions Insurance Industry Anil Chitale Plainsboro New Jersey
COMMUNIQUÉ DE PRESSE publié le 05/01/2024 à 23:15, il y a 2 années 4 mois Guanajuato Silver Arranges Debt Settlement Guanajuato Silver Company Ltd. has announced a debt settlement arrangement to settle outstanding liabilities with the issuance of common shares. The settlement includes the issuance of shares to suppliers and senior management, with the intention of relying on exemptions from certain requirements. The company's material change report will be filed in connection with this announcement, and the debt settlement is subject to TSX-V acceptance and statutory hold period. Guanajuato Silver is a growing precious metals producer in Mexico, and the news release contains forward-looking statements and information. Common Shares Guanajuato Silver Company Ltd. Debt Settlement TSX-V Acceptance Precious Metals Producer
COMMUNIQUÉ DE PRESSE publié le 05/01/2024 à 22:30, il y a 2 années 4 mois Vicinity Motor Corp. Issues DSUs Vicinity Motor Corp. has announced the granting of Deferred Share Units (DSUs) in connection with Directors Remuneration for the fourth quarter of 2023. Certain Eligible Directors have requested that their respective director's remuneration for the calendar year 2023 be paid in DSUs. Vicinity Motor Corp. is a North American supplier of electric vehicles for both public and commercial enterprise use, leveraging a dealer network and close relationships with world-class manufacturing partners to supply its flagship electric, CNG and clean-diesel Vicinity buses, as well as the VMC 1200 electric truck to the transit and industrial markets. Vicinity Motor Corp. Deferred Share Units DSUs Electric Vehicles Director's Remuneration
Publié le 15/05/2026 à 15:08, il y a 21 heures 20 minutes Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Publié le 15/05/2026 à 15:00, il y a 21 heures 28 minutes Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Publié le 15/05/2026 à 10:09, il y a 1 jour 2 heures Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Publié le 14/05/2026 à 09:03, il y a 2 jours 3 heures Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Publié le 13/05/2026 à 18:02, il y a 2 jours 18 heures ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Publié le 16/05/2026 à 01:15, il y a 11 heures 13 minutes Findev Inc. Announces a New Member of the Board of Directors
Publié le 16/05/2026 à 00:00, il y a 12 heures 28 minutes Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Publié le 15/05/2026 à 23:10, il y a 13 heures 18 minutes Golden Minerals Reports First Quarter 2026 Financial Results
Publié le 15/05/2026 à 23:00, il y a 13 heures 28 minutes Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Publié le 15/05/2026 à 20:10, il y a 16 heures 18 minutes CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Publié le 15/05/2026 à 18:10, il y a 18 heures 18 minutes Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Publié le 15/05/2026 à 17:33, il y a 18 heures 55 minutes Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio